Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2016
The Regulatory Role of Long Noncoding RNAs in Cancer Drug ResistanceMarjan E Askarian-Amiri, Euphemia Leung, Graeme Finlay, et al.Bulletin of Mathematical Biology|August 24, 2012
Mathematical determination of cell population doubling times for multiple cell linesLiene Daukste, Britta Basse, Bruce C Baguley, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 15, 2008
IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Zachary J Roberts, Lai-Ming Ching, Stefanie N VogelCurrent Medicinal Chemistry|October 8, 2003
Mechanisms of action of DNA intercalating acridine-based drugs: how important are contributions from electron transfer and oxidative stress?Bruce C Baguley, Laurence P G Wakelin, Jason D Jacintho, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 30, 2004
Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studiesShufeng Zhou, Xia Feng, Philip Kestell, et al.Journal of Drug Targeting|September 5, 2009
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsionSrinivas Ganta, Puneet Sharma, James W Paxton, et al.Molecules (Basel, Switzerland)|January 26, 2021
DNA-Binding Anticancer Drugs: One Target, Two ActionsBruce C Baguley, Catherine J Drummond, Ying Yi Chen, et al.Journal of Medicinal Chemistry|March 7, 2003
Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridinesLeslie W Deady, Thomas Rodemann, Li Zhuang, et al.Cancer Biology & Therapy|March 18, 2010
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivityEuphemia Leung, Nagarajan Kannan, Geoffrey W Krissansen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Population pharmacokinetic-pharmacodynamic model of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid in cancer patientsJing Li, Michael B Jameson, Bruce C Baguley, et al.Pageof 16